Atorvastatin helps the support cells (pericytes) wrap around new blood vessels in plaques more tightly, making them stronger and less likely to leak.

Pro

Against

Evidence from Studies

Supporting (1)

Community contributions welcome

Atorvastatin pleiotropically decreases intraplaque angiogenesis and intraplaque haemorrhage by inhibiting ANGPT2 release and VE-Cadherin internalization

Randomized Controlled Trial

Animal & In Vitro

2021 Aug

Contradicting (0)

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Source Study

Atorvastatin pleiotropically decreases intraplaque angiogenesis and intraplaque haemorrhage by inhibiting ANGPT2 release and VE-Cadherin internalization

Score: 15

DOI: 10.1007/s10456-021-09767-9

Similar Assertions

A common cholesterol drug called atorvastatin can reduce the growth of leaky new blood vessels inside artery plaques, even when it doesn’t lower cholesterol much—this might help prevent plaques from bursting.

90%

Atorvastatin helps make the new blood vessels inside artery plaques less leaky by helping support cells stick better and sealing gaps between vessel lining cells, which may stop bleeding inside the plaque.

86%

In mice prone to clogged arteries, a daily dose of atorvastatin made the dangerous, rupture-prone plaques much less common—even though the overall blockage didn’t get smaller.

79%

The drug lowered levels of two key inflammation signals in the blood, showing it reduces body-wide inflammation even when cholesterol doesn’t change.

78%

The drug reduced the number of inflammatory immune cells inside the artery plaques by nearly 40%, which also made the plaques less fatty and changed their collagen structure.

77%